Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for Ventyx Biosciences, Inc. Common Stock (VTYX).
- Disclosed ownership: 0.3%.
- Date of event: 31 Jan 2026.
MORGAN STANLEY - 31 Jan 2026 SCHEDULE 13G/A Report for Ventyx Biosciences, Inc. Common Stock (VTYX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- VTYX
- Disclosed Ownership
- 237,358 shares
- Ownership
- 0.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Feb 2026, 16:13:53 UTC
- Date of event
- 31 Jan 2026
- Previous filing
- 05 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 0.3% ownership in Ventyx Biosciences, Inc. Common Stock (VTYX) on 31 Jan 2026."
What Changed
- Previous schedule filing date: 05 Feb 2026.
- Current filing was accepted on 06 Feb 2026, 16:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 0.3% | 237,358 | 0 | 237,358 | Christopher O'Hara | Authorized Signatory, Morgan Stanley |